SLU-PP-332 50mg — Vial Spec, Reconstitution Math & COA

A 50mg unit specification of SLU-PP-332 provides high-yield material designed for extensive in vitro screening, high-throughput assays, or long-term preclinical animal models requiring constant stock concentrations. This technical guide outlines reconstitution concentration math, vehicle compatibility, aliquot distribution protocols, and lot-matched quality assurance standards for laboratory investigation.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A 50mg unit specification of SLU-PP-332 provides high-yield material designed for extensive in vitro screening, high-throughput assays, or long-term preclinical animal models requiring constant stock concentrations. This technical guide outlines reconstitution concentration math, vehicle compatibility, aliquot distribution protocols, and lot-matched quality assurance standards for laboratory investigation.

Reviewed by PX1 Research scientific team

Key takeaways

  • In cell culture assays and preclinical metabolic research, SLU-PP-332 serves as a synthetic pan-agonist targeting Estrogen-Related Receptors (specifically ERRα, ERRβ, and ERRγ).
  • When planning experimental assays, laboratories must verify exact catalog specifications.
  • Accurate concentration calculations are vital when reconstituting a 50mg mass to prevent volumetric dosing errors in cell culture media or animal delivery vehicles.
  • SLU-PP-332 is a lipophilic small-molecule ERR agonist and exhibits limited direct solubility in pure aqueous buffers like standard Phosphate-Buffered Saline (PBS).

Overview of SLU-PP-332 50mg Specification & Research Scope

In cell culture assays and preclinical metabolic research, SLU-PP-332 serves as a synthetic pan-agonist targeting Estrogen-Related Receptors (specifically ERRα, ERRβ, and ERRγ). Investigational frameworks prioritize this compound for its capacity to upregulate oxidative skeletal muscle transformation, enhance mitochondrial biogenesis, and modulate fatty acid oxidation pathways without activating classical estrogen receptors. Obtaining a 50mg quantity allows laboratories to maintain a centralized stock, eliminating lot-to-lot variance during multi-week experimental series.

High-throughput screening platforms and automated liquid handlers benefit significantly from a single high-mass vial. A 50mg yield eliminates the operational friction of repeatedly opening and solubilizing smaller unit sizes, thereby mitigating contamination vectors and micro-pipetting drift across longitudinal protocols. Detailed insights regarding receptor binding kinetics can be explored in our SLU-PP-332 mechanism guide.

PX1 Catalog Availability & Formatting Context

When planning experimental assays, laboratories must verify exact catalog specifications. If PX1 Research does not currently list a lyophilized 50mg single-vial format in the active storefront, researchers can utilize alternative standardized formats such as SLU-PP-332 capsules 250mcg or evaluate customized bulk synthesis options.

To review the full range of active inventory, solid-phase synthesized peptides, and small-molecule metabolic modulators available for immediate dispatch, consult our centralized catalog of all peptides. Institutional procurement departments requiring specialized custom fills or dedicated lot reservation can coordinate directly with our team through our wholesale lab portal.

Reconstitution Concentration Math (1mL, 2mL, 3mL Diluent Volumes)

Accurate concentration calculations are vital when reconstituting a 50mg mass to prevent volumetric dosing errors in cell culture media or animal delivery vehicles. Depending on the target working solution, primary stock concentrations vary based on the added volume of compatible laboratory diluent:

• 1.0 mL Addition: Adding 1.0 mL of verified diluent to 50mg of compound yields a primary stock concentration of 50.0 mg/mL (50.0 µg/µL). This ultra-concentrated stock is suitable for high-density master plates or stock storage where minimal vehicle volume is required in final media prep.

• 2.0 mL Addition: Adding 2.0 mL of diluent to 50mg of compound yields a primary stock concentration of 25.0 mg/mL (25.0 µg/µL). This intermediate concentration allows precise volumetric transfer when preparing mid-scale serial dilutions.

• 3.0 mL Addition: Adding 3.0 mL of diluent to 50mg of compound yields a stock concentration of 16.67 mg/mL (16.67 µg/µL). This working density is often preferred when pipetting larger fluid volumes into batch suspension cultures.

Researchers conducting complex serial dilutions or converting mass-to-volume parameters for automated pipetting stations should utilize our interactive reconstitution calculator to verify custom molarity and microgram-per-microliter target values.

Solubilization Profiles & Vehicle Compatibility

SLU-PP-332 is a lipophilic small-molecule ERR agonist and exhibits limited direct solubility in pure aqueous buffers like standard Phosphate-Buffered Saline (PBS). Direct attempt to dissolve a 50mg dry mass directly into saline or water without a co-solvent frequently results in precipitation, cloudiness, or incomplete dissolution.

Optimal reconstitution protocols utilize an organic co-solvent such as high-purity dimethyl sulfoxide (DMSO) to establish an initial master stock solution at 25–50 mg/mL. Once fully dissolved in DMSO, working aliquots can be diluted into secondary vehicle solutions—such as PEG-400, 10% 2-hydroxypropyl-β-cyclodextrin (HPβCD), or culture media containing <0.1% final DMSO concentration—without disrupting compound stability. For comprehensive vehicle selection parameters, refer to our peptide solubility guide.

Aliquot Planning & Thermal Preservation Protocols

Multiple freeze-thaw cycles cause molecular degradation and concentration variance due to solvent evaporation or cryo-precipitation. Once a 50mg vial of SLU-PP-332 is reconstituted into a primary stock, laboratory personnel should immediately divide the solution into single-use working aliquots using sterile, polypropylene microcentrifuge tubes.

• Short-Term Working Solutions: Reconstituted stock in DMSO stored at 2°C to 8°C remains stable for up to 7–14 days, provided the container is tightly sealed against ambient humidity.

• Long-Term Storage: Lyophilized powder prior to reconstitution should be stored at -20°C or -80°C. Reconstituted aliquots stored at -80°C maintain high chemical integrity for extended research cycles.

• Light Exposure: SLU-PP-332 should be protected from direct light exposure using amber vials or foil wraps during handling and storage, as UV radiation can accelerate degradation of synthetic organic molecules.

Lot-Matched Certificate of Analysis (COA) & Analytical Verification

Every production lot provided by PX1 Research undergoes strict analytical testing to confirm chemical identity, purity, and freedom from manufacturing contaminants. Each batch is assigned a lot-specific Certificate of Analysis detailing exact empirical metrics.

• High-Performance Liquid Chromatography (HPLC): Confirms chromatographic purity, ensuring a minimum baseline purity of ≥98.0%.

• Mass Spectrometry (LC-MS): Verifies molecular weight and identity matching the exact structural formula of SLU-PP-332.

Endotoxin Testing: Assessed via Limulus Amebocyte Lysate (LAL) gel-clot assays to ensure low endotoxin levels suitable for sensitive cellular models.

To review verified analytical documentation for your specific lot, access our central COA database.

Comparative Analysis: SLU-PP-332 vs. Other Metabolic Research Compounds

When designing protocols investigating metabolic rate, mitochondrial gene expression, and energy expenditure, researchers frequently compare SLU-PP-332 with other established metabolic reference compounds. Understanding target specificity and receptor mechanisms aids in selecting the correct investigational tool.

Unlike PPAR-δ agonists such as GW-501516 which operate via peroxisome proliferator-activated receptors, SLU-PP-332 acts directly as a pan-agonist on nuclear Estrogen-Related Receptors (ERRs). Similarly, while Rev-ErbA agonists like SR-9009 modulate circadian nuclear receptors and AICAR functions as an indirect AMPK activator, SLU-PP-332 specifically promotes ERR-dependent transcriptional networks governing oxidative phosphorylation and Type I muscle fiber transformation. Combining or contrasting these agents in vitro provides valuable comparative data on cell-autonomous energy regulation.

Scale Assessment: Selecting 50mg vs. Alternate Packaging Options

Choosing between a 50mg mass specification and smaller pre-portioned unit sizes depends entirely on experimental design and facility throughput requirements:

• 50mg Mass Selection: Ideal for multi-well high-throughput screening, core facilities running standardized high-density protocols, or rodent cohorts requiring consistent long-term vehicle dosing from a single analytical lot.

• Smaller Mass Specifications (e.g., 5mg or 10mg): Preferred for pilot feasibility studies, single-plate assays, or assays where long-term solvent storage is impractical due to solvent volatility constraints.

Determining scale requirements early prevents unnecessary material waste and ensures optimal utilization of facility storage resources. Explore broader comparative research data within our research library hub.

ISO 17025 Facility Standards & Distribution Quality

PX1 Research enforces strict quality assurance protocols across manufacturing, handling, and fulfillment. All research-grade compounds are synthesized in GMP-compliant facilities and tested by ISO 17025 accredited independent laboratories located within the United States.

Orders are dispatched from our centralized facilities in California and Arizona. Orders placed Monday through Friday prior to cutoff times qualify for same-day shipping, ensuring rapid delivery and minimizing exposure to ambient environmental fluctuations during transit.

Frequently Asked Questions

What working concentration does a 50mg SLU-PP-332 vial yield when reconstituted with 2mL of vehicle?

Reconstituting a 50mg dry compound mass with 2.0 mL of compatible solvent yields a stock concentration of 25.0 mg/mL (25.0 µg/µL).

Is SLU-PP-332 directly soluble in sterile water or standard PBS?

No. SLU-PP-332 is hydrophobic and requires initial solubilization in an organic solvent like DMSO before further dilution into secondary aqueous buffers.

Does PX1 Research currently offer a single 50mg lyophilized vial of SLU-PP-332?

Product catalog options vary. Researchers should consult the active product list for current unit sizes or evaluate alternative reference formats such as 250mcg encapsulated options or custom bulk procurement.

How should reconstituted SLU-PP-332 stock solutions be stored?

Reconstituted stock solutions in DMSO should be divided into single-use aliquots and stored at -80°C for long-term preservation, protected from light and moisture.

What purity level is guaranteed for PX1 Research SLU-PP-332 lots?

All lots are independently verified via HPLC and LC-MS testing to confirm a chemical purity profile of ≥98.0%.

How does SLU-PP-332 target pathways differ from PPAR-delta agonists?

SLU-PP-332 specifically activates nuclear Estrogen-Related Receptors (ERRα, ERRβ, ERRγ), whereas PPAR-delta agonists target peroxisome proliferator-activated receptor delta transcription factors.

Are PX1 compounds tested for bacterial endotoxins?

Yes. Analytical testing includes LAL gel-clot assay procedures to ensure endotoxin levels meet strict laboratory research standards.

Where are PX1 research compounds synthesized and shipped from?

PX1 compounds are manufactured in USA-based GMP-compliant facilities and dispatched directly from fulfillment centers in California and Arizona.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.